(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are National Energy Services Reunited Corp., ENDRA Life Sciences, and ImmunoGen.

The three biggest losers today are FIRST REPUBLIC BANK, Cloudflare, and Snap.

Winners today

1. National Energy Services Reunited Corp. (NESRW) – 144.44%

NASDAQ ended the session with National Energy Services Reunited Corp. jumping 144.44% to $0.22 on Friday while NASDAQ jumped 0.69% to $12,226.58.

Yearly Top and Bottom Value

National Energy Services Reunited Corp.’s stock is valued at $0.22 at 17:32 EST, way below its 52-week low of $0.11.

More news about National Energy Services Reunited Corp..

2. ENDRA Life Sciences (NDRA) – 24.03%

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

NASDAQ ended the session with ENDRA Life Sciences rising 24.03% to $1.60 on Friday while NASDAQ rose 0.69% to $12,226.58.

Earnings Per Share

As for profitability, ENDRA Life Sciences has a trailing twelve months EPS of $-3.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -146.53%.

Moving Average

ENDRA Life Sciences’s worth is way below its 50-day moving average of $2.90 and way under its 200-day moving average of $4.60.

Yearly Top and Bottom Value

ENDRA Life Sciences’s stock is valued at $1.60 at 17:32 EST, way below its 52-week high of $7.60 and way above its 52-week low of $1.03.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 25.7% and 26.7%, respectively.

More news about ENDRA Life Sciences.

3. ImmunoGen (IMGN) – 22.8%

ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

NASDAQ ended the session with ImmunoGen rising 22.8% to $5.30 on Friday, after three sequential sessions in a row of gains. NASDAQ jumped 0.69% to $12,226.58, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, ImmunoGen has a trailing twelve months EPS of $-0.91.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -92.61%.

More news about ImmunoGen.

4. Meten EdtechX Education Group Ltd. (METXW) – 17%

NASDAQ ended the session with Meten EdtechX Education Group Ltd. jumping 17% to $0.05 on Friday, after five consecutive sessions in a row of losses. NASDAQ rose 0.69% to $12,226.58, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Yearly Top and Bottom Value

Meten EdtechX Education Group Ltd.’s stock is valued at $0.05 at 17:32 EST, above its 52-week high of $0.05.

More news about Meten EdtechX Education Group Ltd..

5. National Energy Services Reunited Corp. (NESR) – 16.98%

National Energy Services Reunited Corp. provides oilfield services to oil and gas companies in the Middle East, North Africa, and the Asia Pacific regions. It operates through two segments, Production Services; and Drilling and Evaluation Services. The Production Services segment offers hydraulic fracturing services; coiled tubing services, including nitrogen lifting, fishing, milling, clean-out, scale removal, and other well applications; stimulation and pumping services; primary and remedial cementing services; nitrogen services; filtration services, as well as frac tanks and pumping units; and pipeline services, such as water filling and hydro testing, nitrogen purging, and de-gassing and pressure testing, as well as cutting/welding and cooling down piping/vessels systems. It also provides production assurance chemicals; laboratory services; artificial lift services; and surface and subsurface safety systems, high-pressure packer systems, flow controls, service tools, expandable liner technology, vacuum insulated tubing technology, and engineering capabilities with manufacturing capacity and testing facilities, as well as sources, treats, and disposes water for oil and gas, municipal, and industrial use. The Drilling and Evaluation Services segment offers drilling and workover rigs; rig services; fishing and remedial solutions; directional and turbines drilling services; drilling fluid systems and related technologies; wireline logging services; slickline services for removal of scale, wax and sand build-up, setting plugs, changing out gas lift valves, and fishing and other well applications; and well testing services to measure solids, gas, and oil and water produced from a well, as well as rents drilling tools. It also provides oilfield solutions for thru-tubing intervention; tubular running services; and a range of wellhead products, flow control equipment, and frac equipment. The company was incorporated in 2017 and is headquartered in Houston, Texas.

NASDAQ ended the session with National Energy Services Reunited Corp. rising 16.98% to $3.10 on Friday, after three successive sessions in a row of losses. NASDAQ rose 0.69% to $12,226.58, after two successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, National Energy Services Reunited Corp. has a trailing twelve months EPS of $0.37.

PE Ratio

National Energy Services Reunited Corp. has a trailing twelve months price to earnings ratio of 8.38. Meaning, the purchaser of the share is investing $8.38 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.88%.

More news about National Energy Services Reunited Corp..

6. Tennant (TNC) – 12.3%

Tennant Company, together with its subsidiaries, designs, manufactures, and markets floor cleaning equipment in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers a suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair services, and asset management solutions. It also provides business solutions, such as financing, rental, and leasing programs, as well as machine-to-machine asset management solutions. The company offers its products under the Tennant, Nobles, Alfa Uma Empresa Tennant, IRIS, IPC, VLX, Gaomei, and Rongen brands, as well as private-label brands. Its products are used in retail establishments and distribution centers; factories and warehouses; and public venues, such as arenas and stadiums, office buildings, schools and universities, hospitals and clinics, parking lots and streets, and other environments. It markets its products to contract cleaners and businesses through direct sales and service organizations, as well as through a network of authorized distributors. Tennant Company was founded in 1870 and is headquartered in Eden Prairie, Minnesota.

NYSE ended the session with Tennant rising 12.3% to $74.78 on Friday while NYSE rose 0.74% to $15,545.88.

Earnings Per Share

As for profitability, Tennant has a trailing twelve months EPS of $3.64.

PE Ratio

Tennant has a trailing twelve months price to earnings ratio of 20.54. Meaning, the purchaser of the share is investing $20.54 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.62%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Tennant’s EBITDA is 49.28.

Yearly Top and Bottom Value

Tennant’s stock is valued at $74.78 at 17:32 EST, higher than its 52-week high of $74.18.

Moving Average

Tennant’s value is way higher than its 50-day moving average of $67.80 and way above its 200-day moving average of $64.10.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.3%, now sitting on 1.09B for the twelve trailing months.

More news about Tennant.

7. Mercurity Fintech Holding (MFH) – 11.38%

Mercurity Fintech Holding Inc. engages in the design, development, creation, testing, installation, configuration, integration, and customization of digital asset infrastructure solutions based on blockchain technologies in the British Virgin Islands and the Asia pacific region. The company provides digital asset trading infrastructure solutions based on internet and blockchain technologies for traders, communities, and liquidity providers; an asset digitalization platform, which provides blockchain-based digitalization solutions for traditional assets that include fiat currencies, bonds, and precious metals. It also offers a decentralized finance platform that solves retail traders' problems; cross-border payments services through NBpay; and supplemental services for its platforms, such as customized software development, maintenance, and compliance support services. The company was formerly known as JMU Limited and changed its name to Mercurity Fintech Holding Inc. in April 2020. Mercurity Fintech Holding Inc. was incorporated in 2011 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Mercurity Fintech Holding rising 11.38% to $1.37 on Friday, after four successive sessions in a row of losses. NASDAQ jumped 0.69% to $12,226.58, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Mercurity Fintech Holding has a trailing twelve months EPS of $-0.63.

Moving Average

Mercurity Fintech Holding’s worth is way higher than its 50-day moving average of $1.17 and way higher than its 200-day moving average of $1.01.

Volume

Today’s last reported volume for Mercurity Fintech Holding is 1440890 which is 738.26% above its average volume of 171890.

Yearly Top and Bottom Value

Mercurity Fintech Holding’s stock is valued at $1.37 at 17:32 EST, way under its 52-week high of $2.15 and way higher than its 52-week low of $0.53.

More news about Mercurity Fintech Holding.

8. Meten EdtechX Education Group Ltd. (METX) – 11.28%

Meten EdtechX Education Group Ltd. provides English language training (ELT) services in the People's Republic of China. It operates through four segments: General Adult English Training, Overseas Training Services, Online English Training, and Junior English Training. The company delivers English language and future skills training for Chinese students and professionals. It offers adult and junior ELT services under the Meten brand name, junior ELT services under the ABC brand name, and online ELT services under the Likeshuo brand name through a digital platform and network of learning centers. As of December 31, 2020, the company had a network of 105 self-operated learning centers covering 28 cities in 15 provinces, autonomous regions, and municipalities, as well as 13 franchised learning centers covering 12 cities in 11 provinces and municipalities. Meten EdtechX Education Group Ltd. was founded in 2006 and is based in Shenzhen, the People's Republic of China.

NASDAQ ended the session with Meten EdtechX Education Group Ltd. jumping 11.28% to $0.22 on Friday, after five successive sessions in a row of losses. NASDAQ rose 0.69% to $12,226.58, after two sequential sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Meten EdtechX Education Group Ltd. has a trailing twelve months EPS of $0.06.

PE Ratio

Meten EdtechX Education Group Ltd. has a trailing twelve months price to earnings ratio of 3.75. Meaning, the purchaser of the share is investing $3.75 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.87%.

Volume

Today’s last reported volume for Meten EdtechX Education Group Ltd. is 174955 which is 61.97% below its average volume of 460096.

More news about Meten EdtechX Education Group Ltd..

9. Viking Therapeutics (VKTX) – 8.77%

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

NASDAQ ended the session with Viking Therapeutics jumping 8.77% to $21.33 on Friday, following the last session’s upward trend. NASDAQ jumped 0.69% to $12,226.58, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.83.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.67%.

More news about Viking Therapeutics.

10. Canaan (CAN) – 8.66%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.

NASDAQ ended the session with Canaan jumping 8.66% to $2.76 on Friday while NASDAQ jumped 0.69% to $12,226.58.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $0.39.

PE Ratio

Canaan has a trailing twelve months price to earnings ratio of 7.08. Meaning, the purchaser of the share is investing $7.08 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.74%.

Moving Average

Canaan’s value is below its 50-day moving average of $2.84 and way under its 200-day moving average of $3.08.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canaan’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for Canaan is 2315520 which is 11.97% above its average volume of 2067870.

More news about Canaan.

Losers Today

1. FIRST REPUBLIC BANK (FRC) – -47.58%

First Republic Bank, together with its subsidiaries, provides private banking, private business banking, and private wealth management services to clients in metropolitan areas in the United States. It operates in two segments, Commercial Banking and Wealth Management. The company accepts deposit products, such as noninterest-bearing checking, interest-bearing checking, money market checking accounts, money market savings accounts, and passbook accounts, as well as certificates of deposit. It also offers a range of lending products that comprise residential mortgage loans, home equity lines of credit, multifamily loans, commercial real estate and construction loans, personal and business loans, single family construction loans, and other loans and lines of credit to businesses and individuals. The company's loans are secured by single family residences, multifamily buildings, and commercial real estate properties. In addition, it provides wealth management services, which include various investment strategies and products, online investment management, trust and custody, full service and online brokerage, financial and estate planning, and access to alternative investments, as well as investing, insurance, and foreign exchange services. Further, the company offers online and mobile banking services; refinancing services; and ATM and debit cards. First Republic Bank was founded in 1985 and is headquartered in San Francisco, California.

NYSE ended the session with FIRST REPUBLIC BANK falling 47.58% to $3.25 on Friday while NYSE jumped 0.74% to $15,545.88.

Earnings Per Share

As for profitability, FIRST REPUBLIC BANK has a trailing twelve months EPS of $8.97.

PE Ratio

FIRST REPUBLIC BANK has a trailing twelve months price to earnings ratio of 0.36. Meaning, the purchaser of the share is investing $0.36 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.99%.

Sales Growth

FIRST REPUBLIC BANK’s sales growth is negative 17.8% for the current quarter and negative 47.8% for the next.

Volume

Today’s last reported volume for FIRST REPUBLIC BANK is 125172000 which is 183.18% above its average volume of 44202400.

Volatility

FIRST REPUBLIC BANK’s last week, last month’s, and last quarter’s current intraday variation average was a negative 35.23%, a negative 5.64%, and a positive 8.91%.

FIRST REPUBLIC BANK’s highest amplitude of average volatility was 44.71% (last week), 10.35% (last month), and 8.91% (last quarter).

Moving Average

FIRST REPUBLIC BANK’s value is way under its 50-day moving average of $74.11 and way under its 200-day moving average of $121.44.

More news about FIRST REPUBLIC BANK.

2. Cloudflare (NET) – -23.17%

CloudFlare, Inc. operates as a cloud services provider that delivers a range of services to businesses worldwide. The company provides an integrated cloud-based security solution to secure a range of combination of platforms, including public cloud, private cloud, on-premise, software-as-a-service applications, and IoT devices; and website and application security products comprising web application firewall, bot management, distributed denial of service, API gateways, SSL/TLS encryption, secure origin connection, and rate limiting products. It also offers website and application performance solutions, including content delivery, load balancing, DNS, agro smart routing, video stream delivery, content optimization, virtual backbone, always online, and cloudflare waiting room and registrar; and network services, which deliver network connectivity, security, and performance to customers as a service, including WAN, WARP, magic transit, magic firewall, cloudflare network interconnect, and spectrum. In addition, the company provides zero trust services, such as cloudflare access, cloudflare gateway, remote browser isolation, cloud access security broker, cloudflare area 1 email security, and data loss prevention products that protect, inspect, and privilege data. Further, it provides developer-based solutions consisting of cloudflare workers, pages, stream, and images, as well as Cloudflare Data Localization suite, a tool that set rules and controls at the network edge; durable objects and R2 object storage products; Consumer DNS Resolver, a consumer app to browse the Internet; and consumer VPN for consumers to secure and accelerate traffic on mobile devices. The company serves customers in the technology, healthcare, financial services, consumer and retail, and non-profit industries, as well as government. CloudFlare, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

NYSE ended the session with Cloudflare dropping 23.17% to $45.78 on Friday, after four consecutive sessions in a row of gains. NYSE jumped 0.74% to $15,545.88, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Cloudflare has a trailing twelve months EPS of $-0.56.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.09%.

Moving Average

Cloudflare’s value is way below its 50-day moving average of $53.52 and way under its 200-day moving average of $53.72.

Previous days news about Cloudflare

• Cloudflare (net) tops Q1 earnings estimates. According to Zacks on Thursday, 27 April, "While Cloudflare has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Cloudflare.

3. Snap (SNAP) – -18.76%

Snap Inc. operates as a technology company in North America, Europe, and internationally. The company offers Snapchat, a visual messaging application with various tabs, such as camera, visual messaging, snap map, stories, and spotlight that enable people to communicate visually through short videos and images. It also provides Spectacles, an eyewear product that connects with Snapchat and captures photos and video from a human perspective; and advertising products, including AR ads and Snap ads comprises a single image or video ads, story ads, collection ads, dynamic ads, and commercials. The company was formerly known as Snapchat, Inc. and changed its name to Snap Inc. in September 2016. Snap Inc. was founded in 2010 and is headquartered in Santa Monica, California.

NYSE ended the session with Snap falling 18.76% to $8.53 on Friday, after two consecutive sessions in a row of gains. NYSE jumped 0.74% to $15,545.88, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Snap shares tank on AI investment plans: what else caused analysts to cut price targets?Shares of Snap Inc (NYSE:SNAP) Friday crashed in premarket trading, after the company reported a first-quarter revenue miss. , SNAP Price Action: Shares of Snap had declined by 19% to $8.51at the time of publishing Friday.

Earnings Per Share

As for profitability, Snap has a trailing twelve months EPS of $-0.86.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.88%.

Volatility

Snap’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.44%, a negative 0.51%, and a positive 3.11%.

Snap’s highest amplitude of average volatility was 1.84% (last week), 2.09% (last month), and 3.11% (last quarter).

Volume

Today’s last reported volume for Snap is 74302600 which is 120.07% above its average volume of 33762500.

Previous days news about Snap

• Snap stock plunges 20% as revenue misses estimates. According to MarketWatch on Thursday, 27 April, "We are working to accelerate our revenue growth and we are using this opportunity to make significant improvements to our advertising platform to help drive increased return on investment for our advertising partners," Snap Chief Executive Evan Spiegel said in a statement announcing the results."
• Snap (snap) Q1 earnings beat estimates. According to Zacks on Thursday, 27 April, "While Snap has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Snap.

4. Seres Therapeutics (MCRB) – -16.87%

Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-287 that is in Phase IIb clinical trial to treat ulcerative colitis; SER-401, which is in Phase Ib clinical trial for use with checkpoint inhibitors in patients with metastatic melanoma; and SER-301 that is in the Phase 1b clinical trial for the treatment of inflammatory bowel disease. In addition, the company engages in the development of SER-262 to treat an initial recurrence of CDI; and SER-155, a cultivated bacteria microbiome drug designed to prevent mortality due to gastrointestinal infections, bacteremia, and graft versus host diseases in immunocompromised patients receiving allogeneic hematopoietic stem cell transplantation and solid organ transplants. It has license and collaboration agreements with Nestec Ltd. and Memorial Sloan Kettering Cancer Center. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Seres Therapeutics sliding 16.87% to $5.32 on Friday, following the last session’s downward trend. NASDAQ jumped 0.69% to $12,226.58, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Seres Therapeutics has a trailing twelve months EPS of $-2.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -351.62%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Seres Therapeutics’s EBITDA is -8.28.

More news about Seres Therapeutics.

5. Pinterest (PINS) – -15.79%

Pinterest, Inc. operates as a visual discovery engine in the United States and internationally. The company's engine allows people to find ideas, such as recipes, home and style inspiration, and others; provides video, product, and idea pins; and offers organizing and planning tools. It shows organic recommendations and advertising engine based on pinners tastes and preferences; and enables pinners with shoppable product pins, which include price, color, and size that redirect to retailer websites. The company was formerly known as Cold Brew Labs Inc. and changed its name to Pinterest, Inc. in April 2012. Pinterest, Inc. was incorporated in 2008 and is headquartered in San Francisco, California.

NYSE ended the session with Pinterest dropping 15.79% to $22.97 on Friday while NYSE rose 0.74% to $15,545.88.

Earnings Per Share

As for profitability, Pinterest has a trailing twelve months EPS of $-0.14.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.04%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.6%, now sitting on 2.8B for the twelve trailing months.

Previous days news about Pinterest

• Pinterest (pins) upgraded to buy: here's what you should know. According to Zacks on Wednesday, 26 April, "As such, the Zacks rating upgrade for Pinterest is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.", "The upgrade of Pinterest to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term."

More news about Pinterest.

6. Aspen Group (ASPU) – -9.46%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group sliding 9.46% to $0.09 on Friday, after three successive sessions in a row of losses. NASDAQ rose 0.69% to $12,226.58, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.47.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.28%.

More news about Aspen Group.

7. Jiayin Group (JFIN) – -8.37%

Jiayin Group Inc. operates as an online individual finance platform that connects individual investors and individual borrowers in China. It operates a secure and open platform that facilitates transparent, secure, and fast connections between investors and borrowers. The company was founded in 2011 and is based in Shanghai, the People's Republic of China.

NASDAQ ended the session with Jiayin Group dropping 8.37% to $3.94 on Friday while NASDAQ jumped 0.69% to $12,226.58.

Earnings Per Share

As for profitability, Jiayin Group has a trailing twelve months EPS of $3.11.

PE Ratio

Jiayin Group has a trailing twelve months price to earnings ratio of 1.27. Meaning, the purchaser of the share is investing $1.27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 186.27%.

Yearly Top and Bottom Value

Jiayin Group’s stock is valued at $3.94 at 17:32 EST, way below its 52-week high of $4.68 and way above its 52-week low of $1.57.

Moving Average

Jiayin Group’s value is way higher than its 50-day moving average of $3.41 and way higher than its 200-day moving average of $2.73.

Revenue Growth

Year-on-year quarterly revenue growth grew by 186.4%, now sitting on 3.27B for the twelve trailing months.

Sales Growth

Jiayin Group’s sales growth is negative 3.5% for the present quarter and 141.9% for the next.

More news about Jiayin Group.

8. Medigus Ltd. (MDGSW) – -8.21%

NASDAQ ended the session with Medigus Ltd. sliding 8.21% to $0.10 on Friday while NASDAQ rose 0.69% to $12,226.58.

Yearly Top and Bottom Value

Medigus Ltd.’s stock is valued at $0.10 at 17:32 EST, under its 52-week high of $0.10 and higher than its 52-week low of $0.10.

More news about Medigus Ltd..

9. American Public Education (APEI) – -6.44%

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education and career learning. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 136 degree programs and 115 certificate programs in various fields of study, including nursing, public health, public administration, and business administration. It also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, and an associate degree in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.

NASDAQ ended the session with American Public Education dropping 6.44% to $5.67 on Friday, after three consecutive sessions in a row of losses. NASDAQ rose 0.69% to $12,226.58, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, American Public Education has a trailing twelve months EPS of $-5.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -30.05%.

Sales Growth

American Public Education’s sales growth is negative 0.8% for the current quarter and negative 0.2% for the next.

Volume

Today’s last reported volume for American Public Education is 123897 which is 64.18% below its average volume of 345943.

More news about American Public Education.

10. Jaguar Health (JAGX) – -5.45%

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through two reportable segments, Human Health and Animal Health. The company, through its subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. It markets Mytesi, a crofelemer 125 mg delayed-release tablet for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. It develops Mytesi for multiple possible follow-on indications, including diarrhea related to targeted cancer therapy; orphan-drug indications for infants and children with congenital diarrheal disorders and short bowel syndrome; supportive care for inflammatory bowel disease; irritable bowel syndrome; and for idiopathic/functional diarrhea, as well as a second-generation proprietary anti-secretory agent is in development for cholera. The company also develops Crofelemer, a drug product candidate for chemotherapy-induced diarrhea in dogs. Jaguar Health, Inc. was incorporated in 2013 and is headquartered in San Francisco, California.

NASDAQ ended the session with Jaguar Health falling 5.45% to $0.52 on Friday while NASDAQ jumped 0.69% to $12,226.58.

Earnings Per Share

As for profitability, Jaguar Health has a trailing twelve months EPS of $-40.67.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -922.07%.

Moving Average

Jaguar Health’s worth is way below its 50-day moving average of $1.19 and way below its 200-day moving average of $9.48.

Revenue Growth

Year-on-year quarterly revenue growth grew by 56.7%, now sitting on 11.96M for the twelve trailing months.

Yearly Top and Bottom Value

Jaguar Health’s stock is valued at $0.52 at 17:32 EST, way under its 52-week high of $36.75 and way above its 52-week low of $0.46.

More news about Jaguar Health.

Stay up to date with our winners and losers daily report